NCT07415031 2026-04-08
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Mirati Therapeutics Inc.
Phase 2 Not yet recruiting
Mirati Therapeutics Inc.
Catharina Ziekenhuis Eindhoven
Multitude Therapeutics Inc.
Fudan University
UNICANCER
Tianjin Medical University Cancer Institute and Hospital
Luye Pharma Group Ltd.
Sixth Affiliated Hospital, Sun Yat-sen University